Graciela Moya

901 total citations
18 papers, 276 citations indexed

About

Graciela Moya is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Graciela Moya has authored 18 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Genetics. Recurrent topics in Graciela Moya's work include Pharmacogenetics and Drug Metabolism (6 papers), Ethics and bioethics in healthcare (3 papers) and Genetic Syndromes and Imprinting (2 papers). Graciela Moya is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Ethics and bioethics in healthcare (3 papers) and Genetic Syndromes and Imprinting (2 papers). Graciela Moya collaborates with scholars based in Argentina, Spain and Mexico. Graciela Moya's co-authors include Karen L. David, Marc Abramowicz, Orit Reish, Françoise Meire, Julie Désir, Nicole Van Regemorter, José María Sánchez, Adrián LLerena, Eva Peñas‐Lledó and Eduardo Tarazona‐Santos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Pharmacology & Therapeutics and Journal of Medical Genetics.

In The Last Decade

Graciela Moya

16 papers receiving 258 citations

Peers

Graciela Moya

GENET

PHARM

RNMI

PPCH

Mukesh Tanwar India

F. A. Hörster Germany

Kaoru Miyahara Japan

Shinitsu Hatakeyama Japan

Jiman He China

Milagros Salas‐Prato Canada

Majbritt Busk Madsen Denmark

Ines Cilenšek Slovenia

Lucia Klimčáková Slovakia

Mukesh Tanwar India

Graciela Moya

78 ×0.9

GENET

240 ×2.9

9 ×0.1

PHARM

121 ×2.2

RNMI

21 ×0.4

PPCH

Citations per year, relative to Graciela Moya Graciela Moya (= 1×) peers Mukesh Tanwar

Countries citing papers authored by Graciela Moya

Since Specialization

Citations

This map shows the geographic impact of Graciela Moya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graciela Moya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graciela Moya more than expected).

Fields of papers citing papers by Graciela Moya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graciela Moya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graciela Moya. The network helps show where Graciela Moya may publish in the future.

Co-authorship network of co-authors of Graciela Moya

This figure shows the co-authorship network connecting the top 25 collaborators of Graciela Moya. A scholar is included among the top collaborators of Graciela Moya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graciela Moya. Graciela Moya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Sosa‐Macías, Martha, Ingrid Fricke-Galindo, Humberto Fariñas, et al.. (2023). Pharmacogenetics: Ethnicity, Treatment and Health in Latin American Populations. Pharmacogenomics. 24(9). 489–492. 3 indexed citations

Peñas‐Lledó, Eva, Enrique Terán, Carlos Galaviz‐Hernández, et al.. (2020). Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting. Clinical Therapeutics. 42(8). 1595–1610.e5. 14 indexed citations

Moya, Graciela. (2020). Un enfoque personalista ontológico de los dilemas surgidos en la pandemia COVID-19. SHILAP Revista de lepidopterología. 3(1). 22–32.

Rodrigues‐Soares, Fernanda, Eva Peñas‐Lledó, Eduardo Tarazona‐Santos, et al.. (2019). Genomic Ancestry,CYP2D6,CYP2C9, andCYP2C19Among Latin Americans. Clinical Pharmacology & Therapeutics. 107(1). 257–268. 38 indexed citations

Miranda, Ana, et al.. (2019). Clinical features and possible founder mutation of the 8bp duplication mutation in the SLC4A11 gene causing corneal dystrophy and perceptive deafness in three South American families. Ophthalmic Genetics. 40(2). 91–98. 2 indexed citations

Moya, Graciela. (2016). Rights of persons with conditions associated with disability: Current legal framework. Archivos Argentinos de Pediatria. 114(4). 355–60. 2 indexed citations

Moya, Graciela, et al.. (2016). High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina. The Pharmacogenomics Journal. 17(4). 378–381. 8 indexed citations

Moya, Graciela. (2016). Valoración ética de las nuevas opciones reproductivas en las enfermedades mitocondriales. Acta bioethica. 22(2). 213–220.

Sosa‐Macías, Martha, Enrique Terán, William F. Waters, et al.. (2016). Pharmacogenetics and Ethnicity: Relevance for Clinical Implementation, Clinical Trials, Pharmacovigilance and Drug Regulation in Latin America. Pharmacogenomics. 17(16). 1741–1747. 12 indexed citations

10.

Sosa‐Macías, Martha, Graciela Moya, Adrián LLerena, et al.. (2015). Population Pharmacogenetics of Ibero-Latinoamerican Populations (MESTIFAR 2014). Pharmacogenomics. 16(7). 673–676. 9 indexed citations

11.

Moya, Graciela. (2012). La aplicación del principio de subsidiariedad en el empoderamiento de los pacientes para el cuidado de la salud: el caso de las enfermedades raras en Argentina. Acta bioethica. 18(2). 181–188. 2 indexed citations

12.

Désir, Julie, Graciela Moya, Orit Reish, et al.. (2007). Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy. Journal of Medical Genetics. 44(5). 322–326. 119 indexed citations

13.

Moya, Graciela, et al.. (2002). Prenatal Diagnosis of L1 Cell Adhesion Molecule Mutations. Fetal Diagnosis and Therapy. 17(2). 115–119. 5 indexed citations

14.

Zurrú, María Cristina, et al.. (2002). [Cadasil: a case with molecular diagnosis].. PubMed. 62(1). 48–52. 3 indexed citations

15.

Kuchinka, Brian D., Irene Barrett, Graciela Moya, et al.. (2001). Two cases of confined placental mosaicism for chromosome 4, including one with maternal uniparental disomy. Prenatal Diagnosis. 21(1). 36–39. 21 indexed citations

16.

Sánchez, José María & Graciela Moya. (1998). Fluconazole teratogenicity. Prenatal Diagnosis. 18(8). 862–863. 1 indexed citations

17.

Sánchez, José María & Graciela Moya. (1998). Fluconazole teratogenicity. Prenatal Diagnosis. 18(8). 862–863. 13 indexed citations

18.

Sánchez, José María, et al.. (1997). Severe Fetal Malformations Associated with Trisomy 16 confined to the Placenta. Prenatal Diagnosis. 17(8). 777–779. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact